These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 34352040

  • 1. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection.
    Cirillo PDR, Margiotti K, Fabiani M, Barros-Filho MC, Sparacino D, Cima A, Longo SA, Cupellaro M, Mesoraca A, Giorlandino C.
    PLoS One; 2021; 16(8):e0255804. PubMed ID: 34352040
    [Abstract] [Full Text] [Related]

  • 2. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
    Tuncer SB, Erdogan OS, Erciyas SK, Saral MA, Celik B, Odemis DA, Turkcan GK, Yazici H.
    J Ovarian Res; 2020 Aug 27; 13(1):99. PubMed ID: 32854743
    [Abstract] [Full Text] [Related]

  • 3. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.
    Lancet Oncol; 2015 Jul 27; 16(7):804-15. PubMed ID: 26088272
    [Abstract] [Full Text] [Related]

  • 4. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.
    Mol Oncol; 2014 Jul 27; 8(5):874-83. PubMed ID: 24694649
    [Abstract] [Full Text] [Related]

  • 5. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T, Gumusoglu E, Dogan B, Ertem FB, Hosseini MK, Cevik N, Senol T, Topuz S, Aydinli K.
    Arch Gynecol Obstet; 2018 Dec 27; 298(6):1173-1180. PubMed ID: 30264202
    [Abstract] [Full Text] [Related]

  • 6. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
    Chung YW, Bae HS, Song JY, Lee JK, Lee NW, Kim T, Lee KW.
    Int J Gynecol Cancer; 2013 May 27; 23(4):673-9. PubMed ID: 23542579
    [Abstract] [Full Text] [Related]

  • 7. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 27; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 8. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X.
    World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
    Kan CW, Hahn MA, Gard GB, Maidens J, Huh JY, Marsh DJ, Howell VM.
    BMC Cancer; 2012 Dec 28; 12():627. PubMed ID: 23272653
    [Abstract] [Full Text] [Related]

  • 11. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer.
    Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W, Chen K.
    PLoS One; 2013 Dec 28; 8(11):e77853. PubMed ID: 24223734
    [Abstract] [Full Text] [Related]

  • 12. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K, Sawada K, Yoshimura A, Kinose Y, Nakatsuka E, Kimura T.
    Mol Cancer; 2016 Jun 24; 15(1):48. PubMed ID: 27343009
    [Abstract] [Full Text] [Related]

  • 13. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.
    J Thorac Oncol; 2011 Mar 24; 6(3):482-8. PubMed ID: 21258252
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X, Zhang H, Cong H, Wang X, Ni H, Shen X, Ju S.
    Pathol Oncol Res; 2018 Oct 24; 24(4):739-744. PubMed ID: 29520570
    [Abstract] [Full Text] [Related]

  • 15. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.
    Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J, Wang C.
    Br J Cancer; 2014 Nov 11; 111(10):1985-92. PubMed ID: 25233400
    [Abstract] [Full Text] [Related]

  • 16. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.
    Zuberi M, Khan I, Mir R, Gandhi G, Ray PC, Saxena A.
    PLoS One; 2016 Nov 11; 11(4):e0153902. PubMed ID: 27092777
    [Abstract] [Full Text] [Related]

  • 17. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B, Olstad OK, Haug KB, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B.
    BMC Cancer; 2014 Feb 11; 14():80. PubMed ID: 24512620
    [Abstract] [Full Text] [Related]

  • 18. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
    Lu C, Lin S, Wen Z, Sun C, Ge Z, Chen W, Li Y, Zhang P, Wu Y, Wang W, Chen S, Zhou H, Li X, Li H, Tao L, Hu Y, Zhao Z, Chen Z, Wu X, Lai Y.
    Biomarkers; 2024 Jul 11; 29(5):276-284. PubMed ID: 38767408
    [Abstract] [Full Text] [Related]

  • 19. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY, Sun L, Guo ZR, Li JC, Bai TT, Cai XX, Li WH, Zhu YF.
    J Ovarian Res; 2019 Jan 22; 12(1):6. PubMed ID: 30670062
    [Abstract] [Full Text] [Related]

  • 20. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P, Åkesson A, Hedenfalk I, Malander S, Borgfeldt C.
    PLoS One; 2020 Jan 22; 15(10):e0240418. PubMed ID: 33075095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.